Just reported
From Iradimed's results release of 2026年10月30日; its quarterly report has since been filed.
Actual
US$24.2M
+14% y/y
+18% q/q
Guided
—
No guide given
Actual
US$0.51
+19% y/y
+24% q/q
Guided
—
No guide given
Actual
US$8.1M
+19% y/y
+27% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →The themes Iradimed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
各项收入占比是对nine months ended September 30, 2026的估算,并非来自已提交报告的数字。
MRidium 3870 MRI-compatible IV infusion pump system
A pump system designed to deliver medicines and fluids in the MRI room. It includes a non-magnetic pump, mobile stand, disposable tubing, and optional remote controls.
MRidium 3860+ MRI-compatible IV infusion pump system
An earlier pump system for delivering medicines and fluids during MRI procedures. IRadimed planned to stop new system sales during 2026 while continuing contracted warranty and technical support.
3880 MRI-compatible patient vital signs monitoring system
A portable monitor that tracks measures such as heart activity, blood oxygen, blood pressure, breathing, and temperature during MRI procedures and patient transport.
3600 ferromagnetic detection system with remote alarm logging unit
Equipment that detects approaching ferromagnetic metal near an MRI room and gives staff a remote screen for viewing alarms and logging items.
MRidium disposable IV tubing sets
Single-use tubing sets that connect the infusion pump to a patient and are made for different types of fluid delivery.
IRadimed makes medical equipment that can operate in the powerful magnetic fields around MRI scanners. Its intravenous (IV) pumps deliver medicines and fluids during scans, while its monitors track patients’ vital signs; both are designed to move with patients between hospital departments and the scanner. It also sells equipment that detects ferromagnetic metal near MRI rooms, along with disposable tubing, maintenance agreements, and repair services.
基于 Iradimed Corp. 自己向美国证券交易委员会(SEC)提交的申报文件。数字如实呈报,每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议,也不是买卖任何证券的推荐。
US$85.35+0.4%11月13日 收盘
数据截至2026年9月30日,来自2026年10月30日提交的10-Q
IRadimed sells infusion pumps designed for use beside magnetic resonance imaging (MRI) scanners to hospitals, plus patient monitors and metal detectors.
Grade A+
价格下方的色带显示每个日期的评级,仅依据当时已公开的文件计算。
显示 Iradimed Corp. 评级历史 41 个季度中的 2 个。 其余 39 个可回溯到 2016年11月。